Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Turcot syndrome × dostarlimab × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 15 Ovarian Neoplasms 10 Uterine Cervical Neoplasms 5 Neoplasm Metastasis 3 Fallopian Tube Neoplasms 3 Carcinoma 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Turcot syndrome 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Neoplasms 1 Ovarian Carcinosarcoma 1 Neoplasms 1 MMRd/MSI-H Stage II-III Endometrial Cancer 1 Gestational Trophoblastic Disease 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Adenocarcinoma, Clear Cell 1

Interventions

pembrolizumab 5 Nivolumab 2 tislelizumab 1 sintilimab 1 durvalumab 1 dostarlimab 1 denileukin diftitox 1 avelumab 1 atezolizumab 1 Taxes 1 Paclitaxel 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1 Interleukin-2 1 Immune Checkpoint Inhibitors 1 E7777 fusion protein 1 Docetaxel 1 Carboplatin 1 Biopsy 1 ALT-803 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06278857 2024-12-03

SATELLITE

Queensland Centre for Gynaecological Cancer

Phase 2 Recruiting

Turcot syndrome, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡